Review article · 2022 · Open access
Blood biomarkers for Alzheimer's disease and related disorders
Acta Neurologica Scandinavica, 146(1), 51–55 · Published 25 April 2022 · DOI 10.1111/ane.13628
In brief
“Blood biomarkers for Alzheimer's disease and related disorders” is a 2022 review article by Henrik Zetterberg and Jonathan M. Schott, published in Acta Neurologica Scandinavica. OpenAlex counts 59 citations as of 18 November 2026, which puts it in the top 2% of works published in 2022 by citations. It is open access: the full text is free to read at UCL Discovery (University College London).
- Citations
- 59
- Most cited in
- 2023 (18)
- Field-weighted impact
- 1.46
- References
- 45
- Authors
- 2
Abstract
Alzheimer's disease (AD) is a progressive neurodegenerative disease and the single commonest cause of dementia. Many other diseases can, however, cause dementia, and differential diagnosis can be challenging, especially in early disease stages. For most neurodegenerative dementias, accumulation of brain pathologies starts many years before clinical onset; the ability to detect these pathologies paves the way for targeted disease-modifying prevention trials. AD is associated with β-amyloid and tau pathologies, which can be quantified using cerebrospinal fluid and imaging biomarkers and, more recently, using highly sensitive blood tests. While for the most part, specific biomarkers of non-AD neurodegenerative dementias are lacking, non-specific biomarkers of neurodegeneration are available. This review summarizes recent advances in the neurodegenerative dementia blood biomarker research and discusses the next steps required for clinical implementation.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Zetterberg, H., & Schott, J. M. (2022). Blood biomarkers for Alzheimer's disease and related disorders. Acta Neurologica Scandinavica, 146(1), 51–55. https://doi.org/10.1111/ane.13628
MLA 9
Zetterberg, Henrik, and Jonathan M. Schott. “Blood biomarkers for Alzheimer's disease and related disorders.” Acta Neurologica Scandinavica, vol. 146, no. 1, 2022, pp. 51–55. https://doi.org/10.1111/ane.13628.
Chicago
Zetterberg, Henrik and Jonathan M. Schott. 2022. “Blood biomarkers for Alzheimer's disease and related disorders.” Acta Neurologica Scandinavica 146 (1): 51–55. https://doi.org/10.1111/ane.13628.
Harvard
Zetterberg, H. and Schott, J. M. (2022) ‘Blood biomarkers for Alzheimer's disease and related disorders’, Acta Neurologica Scandinavica, 146(1), pp. 51–55. doi:10.1111/ane.13628.
IEEE
H. Zetterberg and J. M. Schott, “Blood biomarkers for Alzheimer's disease and related disorders,” Acta Neurologica Scandinavica, vol. 146, no. 1, pp. 51–55, 2022, doi: 10.1111/ane.13628.
BibTeX
@article{zetterberg2022blood,
title = {{Blood biomarkers for Alzheimer's disease and related disorders}},
author = {Zetterberg, Henrik and Schott, Jonathan M.},
journal = {Acta Neurologica Scandinavica},
year = {2022},
volume = {146},
number = {1},
pages = {51--55},
doi = {10.1111/ane.13628},
url = {https://doi.org/10.1111/ane.13628}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Citations by year
| Year | Citations | Share of the best year |
|---|---|---|
| 2022 | 8 | |
| 2023 | 18 | |
| 2024 | 15 | |
| 2025 | 7 | |
| 2026 | 11 |
Its field-weighted citation impact is 1.46: it has been cited 1.46 times as often as the average work of the same field, type and year (1.00 is the world average).
Topic and keywords
Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Alzheimer's disease
- blood biomarkers
- dementia
- neurodegeneration
- amyloid-beta
- tau protein
- cerebrospinal fluid biomarkers
- imaging biomarkers
Work with this paper
Most-cited papers in Medicine
- Yaşlı Kadınlarda Üreme SağlığıDemet Kokanalı, Yaprak Engin Üstün · Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi · 2019 · 169,630 citations
- Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 CountriesHyuna Sung, Adalberto M. Filho, Mathieu Laversanne and 5 more · CA A Cancer Journal for Clinicians · 2021 · 119,885 citations
- “Mini-mental state”Marshal F. Folstein, Susan E. Folstein, Paul R. McHugh · Journal of Psychiatric Research · 1975 · 90,424 citations
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countriesFreddie Bray, Jacques Ferlay, Isabelle Soerjomataram and 3 more · CA A Cancer Journal for Clinicians · 2018 · 87,396 citations
- Hallmarks of Cancer: The Next GenerationDouglas Hanahan, Robert A. Weinberg · Cell · 2011 · 69,758 citations
Questions about this paper
How do I cite this paper in APA style?
Zetterberg, H., & Schott, J. M. (2022). Blood biomarkers for Alzheimer's disease and related disorders. Acta Neurologica Scandinavica, 146(1), 51–55. https://doi.org/10.1111/ane.13628
How many times has this paper been cited?
59 times, according to OpenAlex on 18 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at UCL Discovery (University College London): sign in and open the PDF from this page.
Who wrote this paper?
Henrik Zetterberg, Jonathan M. Schott.
What is the DOI of this paper?
10.1111/ane.13628, permanently at https://doi.org/10.1111/ane.13628. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 18 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.